Riskpilot← Back to searchSign inGet full accessRAM BIOTECH ApS
APSActiveCVR 26923573Blegdamsvej 9Traditional, complementary and alternative medicine activities · NACE 8696Est. 2002— employees
Revenue 2025
DKK -22K
-24% vs 2024
EBITDA margin
100.0%
+24% vs 2024
Equity ratio
92.1%
Financial strength
Net profit 2025
DKK -22K
+24% vs 2024
| Revenue | DKK -22K | -24% |
| EBITDA | DKK -22K | +24% |
| Net profit | DKK -22K | +24% |
| Total assets | DKK 252K | -11% |
| Equity | DKK 232K | -9% |
| Employees | — | — |
Legal name
RAM BIOTECH ApS
CVR number
26923573
Legal form
Anpartsselskab
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
22. november 2002
Share capital
DKK 156.250
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med bestyrelsesformanden eller af en direktør i forening med to bestyrelsesmedlemmer eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at medvirke til kommercialisering af opfindelser vedrørende bekæmpelse af malaria.
Address
Blegdamsvej 9
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -29 | 1 | -33 | 14 | 2 | 48 | 57 | 50 | 47 | 74 | -26 | -25 | -29 | -22 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -29 | 1 | -33 | 14 | 2 | 48 | 57 | 50 | 47 | 74 | -26 | -25 | -29 | -22 |
| Depreciation & amort. | -0 | -0 | -0 | -1.361 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -29 | 1 | -33 | -1.347 | 2 | 48 | 57 | 50 | 47 | 74 | -26 | -25 | -29 | -22 |
| Net financials | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | -2 | -3 | -0 | 0 | 0 |
| Profit before tax | -29 | 0 | -33 | -1.347 | 2 | 48 | 57 | 50 | 47 | 72 | -29 | -25 | -29 | -22 |
| Tax | -7 | -13 | -7 | -92 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -21 | 14 | -26 | -1.255 | 2 | 48 | 57 | 50 | 47 | 72 | -29 | -25 | -29 | -22 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.464 | 1.464 | 1.445 | 103 | 106 | 156 | 216 | 264 | 311 | 390 | 337 | 312 | 281 | 252 |
| Equity | 1.329 | 1.342 | 1.317 | 62 | 64 | 112 | 169 | 218 | 265 | 337 | 308 | 284 | 254 | 232 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 22 | 22 | 36 | 42 | 43 | 45 | 47 | 46 | 46 | 54 | 29 | 28 | 27 | 20 |
| Total debt | 22 | 22 | 36 | 42 | 43 | 45 | 47 | 46 | 46 | 54 | 29 | 28 | 27 | 20 |
EBITDA margin
-2247900.0%
This company
15.8%
Market median
-14227315% vs market
20122025
Equity ratio
92.1%
This company
38.2%
Market median
+141% vs market
20122025
Return on equity
-9.7%
This company
18.4%
Market median
-153% vs market
20122025
Net profit margin
-2247900.0%
This company
8.1%
Market median
-27751952% vs market
20122025
Asset turnover
-0.09×
This company
1.12×
Market median
-108% vs market
20122025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2002 | — | — | |
| Board of Directors | 2004 | — | — | |
| Board of Directors | 2002 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50.0% | 50.0% | 2006 | |
| Individual | 25.0% | 25.0% | 2006 | |
Lundquist Medical ApS | Company | 20.0% | 20.0% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RAM BIOTECH ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rasmus Lundquist | Board of Directors | 0 companies |
| Carsten Schou | Board of Directors | 0 companies |
| Peter Jørgen Lauridsen | Board of Directors | 0 companies |